Global Biologics Contract Research Organization Market Size & Outlook
Global biologics contract research organization market, 2021-2033 (US$M)
Related Markets
Global biologics contract research organization market highlights
- The global biologics contract research organization market generated a revenue of USD 13,657.8 million in 2024 and is expected to reach USD 32,295.7 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 10.2% by 2033.
- In terms of segment, clinical accounted for a revenue of USD 11,250.0 million in 2024.
- Pre-Clinical is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 13,657.8 million |
| Market revenue in 2033 | USD 32,295.7 million |
| Growth rate | 10.2% (CAGR from 2025 to 2033) |
| Largest segment | Clinical |
| Fastest growing segment | Pre-Clinical |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Other key industry trends
- In terms of revenue, the North America accounted for 24.1% of the global biologics contract research organization market in 2024.
- By country, the China is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 5,746.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biologics Contract Research Organization Market Scope
Biologics Contract Research Organization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Blackbird Critical Metals Corp | View profile | - | 1177 West Hastings Street, Suite 2133, Vancouver, BC, Canada, V6E 2K3 | https://www.gamaexplorations.com |
| Syngene | View profile | 1001-5000 | Bangalore, Karnataka, India, Asia | http://www.syngeneintl.com |
| AGC Biologics | View profile | 1001-5000 | Bothell, Washington, United States, North America | http://www.agcbio.com/ |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.parexel.com |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Samsung Electronics Co Ltd | View profile | 124804 | 129, Samsung-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, Korea, Republic of, 443-742 | https://www.samsung.com |
| FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Global biologics contract research organization market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics contract research organization market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 82.37% in 2024. Horizon Databook has segmented the Global biologics contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Biologics Contract Research Organization Type Outlook (Revenue, USD Million, 2021-2033)
- Drug Discovery
- Target Validation
- Lead Identification
- Lead Optimization
- Pre-Clinical
- Clinical
- Drug Discovery
- Global Biologics Contract Research Organization Product Outlook (Revenue, USD Million, 2021-2033)
- Monoclonal Antibodies (mAbs)
- Antibody-Drug Conjugates (ADCs)
- Bispecific/Multispecific Antibodies
- Recombinant Proteins & Enzymes
- Vaccines
- Cell & Gene Therapies
- Nucleic Acid–Based Therapeutics
- Others
- Global Biologics Contract Research Organization Service Outlook (Revenue, USD Million, 2021-2033)
- Project Management/Clinical Supply Management
- Data Management
- Regulatory/Medical Affairs
- Medical Writing
- Clinical Monitoring
- Quality Management/ Assurance
- Bio-statistics
- Investigator Payments
- Laboratory
- Sterility Testing
- Container/Closure Testing
- Extractables and Leachable Testing
- Environmental Monitoring (Including Microbiology Testing)
- Disinfectant Efficacy Studies
- Other
- Patient and Site Recruitment
- Technology
- Others
- Global Biologics Contract Research Organization Therapeutic Area Outlook (Revenue, USD Million, 2021-2033)
- Oncology
- CNS Disorders
- Infectious Diseases
- Immunological Disorders
- Cardiovascular Disease
- Respiratory Diseases
- Diabetes
- Ophthalmology
- Pain Management
- Other
- Global Biologics Contract Research Organization End Use Outlook (Revenue, USD Million, 2021-2033)
- Large Biopharmaceutical Companies
- Small & Mid-Sized Biopharmaceutical Companies
- Others
- Global Biologics Contract Research Organization Clinical Trials Outlook (Revenue, USD Million, 2021-2033)
- Phase I Trial Services
- Phase II Trial Services
- Phase III Trial Services
- Phase IV Trial Services
Reasons to subscribe to Global biologics contract research organization market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biologics contract research organization market databook
-
Our clientele includes a mix of biologics contract research organization market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biologics contract research organization market , including forecasts for subscribers. This global databook contains high-level insights into Global biologics contract research organization market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global biologics contract research organization market size, by regions, 2021-2033 (US$M)
Top 10 countries: Biologics contract research organization market size, 2024 (US$M)
Global biologics contract research organization market share, by type, 2024 & 2033 (%, US$M)
Biologics contract research organization market: Opportunity assessment by country
Global biologics contract research organization market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
